This report provides an overview of the therapeutic area and market size for the 7 major markets.
Executive Summary
- Addressable Patient Pool
- Major Players in the Market
- Market Dynamics
- Market Forecast
Disease Understanding
- Overview
- Etiology
- Symptoms
- Diagnostic Algorithm
- Treatment Algorithm
- Current Standard of Care
7MM Epidemiology Overview
- United States: Epidemiology Outlook
- Disease Burden
- Patient Demographics
- Diagnosed Patient Pool
- Treatable Patient Pool
- Epidemiology Forecast
- EU-5 Countries: Epidemiology Outlook
- Germany Epidemiology Size
- Disease Burden
- Patient Demographics
- Diagnosed Patient Pool
- Treatable Patient Pool
- Epidemiology Forecast
- France Epidemiology Size
- Disease Burden
- Patient Demographics
- Diagnosed Patient Pool
- Treatable Patient Pool
- Epidemiology Forecast
- Italy Epidemiology Size
- Disease Burden
- Patient Demographics
- Diagnosed Patient Pool
- Treatable Patient Pool
- Epidemiology Forecast
- Spain Epidemiology Size
- Disease Burden
- Patient Demographics
- Diagnosed Patient Pool
- Treatable Patient Pool
- Epidemiology Forecast
- United Kingdom Market Outlook
- Disease Burden
- Patient Demographics
- Diagnosed Patient Pool
- Treatable Patient Pool
- Epidemiology Forecast
- Germany Epidemiology Size
- Japan Market Outlook
- Disease Burden
- Patient Demographics
- Diagnosed Patient Pool
- Treatable Patient Pool
- Epidemiology Forecast
Unmet Needs
Emerging Therapies
- Competitive Landscape
- Pipeline Benchmarking
- Key Product Profiles
- Reproxalap Ophthalmic Solution: Aldeyra Therapeutics
- Product Description
- Regulatory Milestones
- Clinical Development
- Safety and efficacy
- ALY688 Ophthalmic Solution: Allysta Pharmaceutical
- Product Description
- Regulatory Milestones
- Clinical Development
- Safety and efficacy
7MM Market Analysis
- Key Insights
- Market Forecast Assumptions
- Market Size of Dry Eye Disease (DED) in 7MM countries
- Market Size of Dry Eye Disease (DED) by therapies in 7MM
- United States: Market Outlook
- Total Market size of Dry Eye Disease (DED) in the US
- Market Size of Dry Eye Disease (DED) by Therapies in the US
- EU-5 Countries: Market Outlook
- Germany Market Size
- Total Market Size of Dry Eye Disease (DED) in Germany
- Market Size of Dry Eye Disease (DED) by Therapies in Germany
- France Market Size
- Total Market Size of Dry Eye Disease (DED) in France
- Market Size of Dry Eye Disease (DED) by Therapies in France
- Italy Market Size
- Total Market Size of Dry Eye Disease (DED) in Italy
- Market Size of Dry Eye Disease (DED) by Therapies in Italy
- Spain Market Size
- Total Market Size of Dry Eye Disease (DED) in Spain
- Market Size of Dry Eye Disease (DED) by Therapies in Spain
- United Kingdom Market Size
- Total Market Size of Dry Eye Disease (DED) in the UK
- Market Size of Dry Eye Disease (DED) by Therapies in the UK
- Germany Market Size
- Japan Market Outlook
- Total Market Size of Dry Eye Disease (DED) in Japan
- Market Size of Dry Eye Disease (DED) by Therapies in Japan
- Market Drivers
- Market Barriers